Genomics in Action: Integrating Pharmacogenomics into the Specialty Pharmacy Workflow

ACPE Activity Number: 0204-0000-26-055-H04-P/T
Release Date: 8/12/2026
Expiration Date: 8/12/2029
Activity Type: Knowledge-based
CE Credits: 1 contact hour
Activity Fee: Member – Free / Non-Member – Not Available

This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.

Activity Overview

Pharmacogenomics is a key component of precision medicine, enabling medication therapy to be tailored to an individual patient’s genetic profile. Specialty pharmacies are uniquely positioned to incorporate pharmacogenomic insights into medication management through routine patient assessments. However, few specialty pharmacy models have integrated pharmacogenomics into daily workflows. The St. Jude Specialty Pharmacy has successfully implemented this approach. This session will describe the role of specialty pharmacy staff in identifying patients eligible for pharmacogenomic testing and provide practical examples of incorporating pharmacogenomic data into initial and follow-up medication assessments. Because specialty pharmacists regularly review patient medication lists, they are well positioned to identify therapies that may be impacted by pharmacogenomic test results.

Accreditation

Target Audience

Learning Objectives

After completing this activity, the learner should be able to:

Describe the benefits of pharmacogenomics on medication-related outcomes across the continuum of care in health-system practice settings.
Summarize resources that explain pharmacogenomics and inform patient-care recommendations.
Identify the roles of specialty pharmacy technicians and pharmacists in integrating pharmacogenomics into the medication care continuum.

Schedule of Activities

Faculty

Tiffany Nason, PharmD
Manager, Specialty Pharmacy
St Jude Children’s Research Hospital
Department of Pharmacy and Pharmaceutical Sciences
Memphis, TN

Cyrine Haidar, PharmD, BCPS, BCOP, DPLA, FASHP
Associate Member
St Jude Children’s Research Hospital
Department of Pharmacy and Pharmaceutical Sciences
Memphis, TN

Relevant Financial Relationship Disclosure

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Methods and CE Requirements

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Online Program

Member

Free

Non-Member

N/A